The holidays are a time to enjoy family, friends, and good cheer, but as we go through this joyous season, many of us struggle with mental health challenges and stress due to a combination of social obligations, financial burdens, and other factors. From going to festive events we may have little interest in attending, to […]
This month, we talked with Eric Spinner, Psy.D. Beginning in September, he will be working at The Center for Anxiety and Mood Disorders as a Post Doctoral Resident. For the past two years before joining the team, Dr. Spinner worked at a residential facility for women, treating adolescents to older adults with eating disorders. As […]
Transcranial magnetic stimulation may help relieve symptoms in those with severe anxiety or depression that doesn’t respond to treatment or medications.
There are seven core issues that follow adopted children into adulthood. These concerns affect them emotionally and must be addressed to begin healing.
Watch a presentation on the Phenomenon of Gaming and It’s Relationship to Anxiety and Depression presentation by Carolyn Rubenstein, Ph.D. and Gabrielle Avery-Peck, Ph.D. from the Center for Treatment of Anxiety and Mood Disorders at the ADAA Conference 2019.
As reviewed in a past article, the field of Psychiatry is unique among medical specialties. At present, medical technology has yet to provide adequate imaging or laboratory testing that would allow for more objective assessment of a patient’s symptoms and concerns. A person with chest pain, fatigue and a racing heartbeat can rest assured that a carefully designed testing protocol will clarify the nature of the problem. Cardiac enzymes, electrocardiogram, chest x-ray and even cardiac catheterization will provide objective evidence to either rule-in or rule-out a cardiac event. Or the severe sore throat that makes swallowing difficult can be objectively clarified by obtaining a throat culture and consequently help the physician chose an antibiotic if indicated.
As of this writing, 30 states, Guam, the District of Columbia, and Puerto Rico all have approved the broad use of medical marijuana. Additionally, other states allow limited medical use and 8 states (and the District of Columbia) allow recreational use of the drug. Even though the use of pot and weed is becoming more acceptable, the Drug Enforcement Administration (DEA) still considers marijuana to be a Schedule I substance, meaning it is likely to be abused and it completely lacks medical value. This classification also means there hasn’t been much research into the efficacy of the drug for medical conditions and, in particular, we lack long-term studies that would tell us whether it is safe and/or effective when used over a long period of time.
Dr. Andrew Rosen, Board Certified Psychologist, founder and director of the Center for Treatment of Anxiety and Mood Disorders and Dr. David Gross, Board Certified Psychiatrist, and medical director of the Center recently held a webinar on using medication versus therapy for anxiety and depression with The Anxiety and Depression Association of America. Some of the topics covered in the webinar include: What are the roles of medication and therapy? How can my psychiatrist (or primary care doctor) and my therapist work together as a team? How soon can I expect to see results from medication? How soon can I expect to see results from cognitive-behavioral therapy (CBT)? Are there situations where medication and CBT can work great together?